Ideaya Biosciences Inc. (IDYA) NASDAQ
$43.88 0.57 (1.32%)
Market Cap: $3.27B
As of 03/28/24 04:00 PM EDT. Market closed.
Ideaya Biosciences Inc. (IDYA)
NASDAQ
$43.88
0.57 (1.32%)
Market Cap: $3.27B
As of 03/28/24 04:00 PM EDT. Market closed.
ideaya biosciences is an oncology-focused biotechnology company committed to the discovery of personalized synthetic lethality medicines targeting dna damage and repair for genetically defined patient populations and immuno-oncology therapies targeting the tumor microenvironment. founded in 2015, ideaya’s investors include 5am ventures (5am), canaan partners (canaan), celgene, wuxi healthcare ... read more
ideaya biosciences is an oncology-focused biotechnology company committed to the discovery of personalized synthetic lethality medicines targeting dna damage and repair for genetically defined patient populations and immuno-oncology therapies targeting the tumor microenvironment. founded in 2015, ideaya’s investors include 5am ventures (5am), canaan partners (canaan), celgene, wuxi healthcare ventures (wuxi), novartis institute of biomedical research, and alexandria real estate. the company has assembled a world-class drug discovery team and scientific advisory board (sab) that is represented by a nobel laureate and three members of the national academy of sciences. ideaya is located in south san francisco and la jolla, california. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Ruiz Briseno Andres | See Remarks | Feb 09, 2024 | Sale | $46.02 | 2,000 | 92,045 | 24,531 | Feb 13, 2024, 04:59 PM |
Hata Yujiro S | President and CEO | Feb 08, 2024 | Option Exercise | $4.31 | 75,815 | 326,763 | 753,702 | Feb 12, 2024, 04:27 PM |
Hata Yujiro S | President and CEO | Feb 09, 2024 | Option Exercise | $4.31 | 23,557 | 101,531 | 701,444 | Feb 12, 2024, 04:27 PM |
Hata Yujiro S | President and CEO | Feb 09, 2024 | Sale | $45.54 | 23,557 | 1,072,715 | 677,887 | Feb 12, 2024, 04:27 PM |
Hata Yujiro S | President and CEO | Feb 08, 2024 | Sale | $45.15 | 75,815 | 3,422,835 | 677,887 | Feb 12, 2024, 04:27 PM |
Hata Yujiro S | President and CEO | Feb 01, 2024 | Option Exercise | $4.31 | 628 | 2,707 | 678,515 | Feb 05, 2024, 06:05 PM |
Hata Yujiro S | President and CEO | Feb 01, 2024 | Sale | $45.00 | 628 | 28,260 | 677,891 | Feb 05, 2024, 06:05 PM |
Ruiz Briseno Andres | See Remarks | Jan 22, 2024 | Sale | $42.03 | 2,000 | 84,050 | 26,531 | Jan 24, 2024, 07:12 PM |
Ruiz Briseno Andres | See Remarks | Jan 12, 2024 | Sale | $38.01 | 2,000 | 76,026 | 28,531 | Jan 17, 2024, 05:41 PM |
Hata Yujiro S | President and CEO | Jan 12, 2024 | Option Exercise | $4.31 | 12,261 | 52,845 | 690,148 | Jan 17, 2024, 05:40 PM |
Hata Yujiro S | President and CEO | Jan 16, 2024 | Option Exercise | $4.31 | 62,739 | 270,405 | 740,626 | Jan 17, 2024, 05:40 PM |
Hata Yujiro S | President and CEO | Jan 12, 2024 | Sale | $40.04 | 12,261 | 490,913 | 677,887 | Jan 17, 2024, 05:40 PM |
Hata Yujiro S | President and CEO | Jan 16, 2024 | Sale | $40.17 | 62,739 | 2,519,968 | 677,887 | Jan 17, 2024, 05:40 PM |
Throne Jason | Chief Legal Officer | Dec 18, 2023 | Option Exercise | $7.01 | 10,000 | 70,100 | 10,000 | Dec 19, 2023, 05:37 PM |
Throne Jason | Chief Legal Officer | Dec 15, 2023 | Option Exercise | $13.34 | 10,000 | 133,400 | 10,000 | Dec 19, 2023, 05:37 PM |
Throne Jason | Chief Legal Officer | Dec 15, 2023 | Sale | $35.04 | 10,000 | 350,371 | 0 | Dec 19, 2023, 05:37 PM |
Hata Yujiro S | President and CEO | Dec 15, 2023 | Option Exercise | $4.31 | 75,000 | 323,250 | 752,887 | Dec 19, 2023, 05:34 PM |
Hata Yujiro S | President and CEO | Dec 15, 2023 | Sale | $35.03 | 75,000 | 2,627,618 | 677,887 | Dec 19, 2023, 05:34 PM |
Ruiz Briseno Andres | See Remarks | Dec 14, 2023 | Sale | $34.00 | 2,000 | 68,002 | 30,859 | Dec 18, 2023, 05:45 PM |
Throne Jason | Chief Legal Officer | Nov 03, 2023 | Option Exercise | $12.86 | 5,163 | 66,396 | 5,163 | Nov 07, 2023, 05:47 PM |
Throne Jason | Chief Legal Officer | Nov 03, 2023 | Sale | $30.09 | 5,163 | 155,360 | 0 | Nov 07, 2023, 05:47 PM |
Throne Jason | Chief Legal Officer | Sep 12, 2023 | Option Exercise | $12.86 | 1,000 | 12,860 | 1,000 | Sep 14, 2023, 05:23 PM |
Throne Jason | Chief Legal Officer | Sep 12, 2023 | Sale | $30.01 | 1,000 | 30,005 | 500 | Sep 14, 2023, 05:23 PM |
Throne Jason | Chief Legal Officer | Sep 05, 2023 | Option Exercise | $12.86 | 1,737 | 22,338 | 1,737 | Sep 06, 2023, 06:37 PM |
Throne Jason | Chief Legal Officer | Sep 01, 2023 | Option Exercise | $12.86 | 2,100 | 27,006 | 2,100 | Sep 06, 2023, 06:37 PM |
Throne Jason | Chief Legal Officer | Sep 05, 2023 | Sale | $30.03 | 1,737 | 52,160 | 0 | Sep 06, 2023, 06:37 PM |
Throne Jason | Chief Legal Officer | Sep 01, 2023 | Sale | $30.03 | 2,100 | 63,063 | 0 | Sep 06, 2023, 06:37 PM |
Ruiz Briseno Andres | See Remarks | Sep 01, 2023 | Sale | $30.01 | 2,000 | 60,016 | 32,531 | Sep 06, 2023, 06:36 PM |
Stone Paul A. | Chief Financial Officer | Aug 29, 2023 | Sale | $28.87 | 5,000 | 144,352 | 9,303 | Aug 31, 2023, 05:49 PM |
Stone Paul A. | Chief Financial Officer | Aug 21, 2023 | Sale | $26.40 | 978 | 25,819 | 14,303 | Aug 23, 2023, 06:31 PM |
Stone Paul A. | Chief Financial Officer | Aug 18, 2023 | Sale | $26.38 | 3,822 | 100,820 | 15,281 | Aug 18, 2023, 06:33 PM |
Stone Paul A. | Chief Financial Officer | Aug 16, 2023 | Sale | $26.43 | 200 | 5,285 | 19,203 | Aug 18, 2023, 06:33 PM |
Throne Jason | Chief Legal Officer | Aug 09, 2023 | Option Exercise | $13.34 | 5,000 | 66,700 | 5,000 | Aug 11, 2023, 07:22 PM |
Throne Jason | Chief Legal Officer | Aug 09, 2023 | Sale | $25.09 | 5,000 | 125,429 | 0 | Aug 11, 2023, 07:22 PM |
Stone Paul A. | Chief Financial Officer | Aug 09, 2023 | Sale | $25.05 | 2,500 | 62,613 | 19,303 | Aug 11, 2023, 07:21 PM |
Throne Jason | Chief Legal Officer | Jul 10, 2023 | Option Exercise | $10.09 | 9,485 | 95,740 | 9,485 | Jul 12, 2023, 05:25 PM |
Throne Jason | Chief Legal Officer | Jul 10, 2023 | Sale | $23.00 | 9,485 | 218,178 | 0 | Jul 12, 2023, 05:25 PM |
Throne Jason | Chief Legal Officer | Jun 01, 2023 | Option Exercise | $7.01 | 3,553 | 24,907 | 3,553 | Jun 02, 2023, 05:29 PM |
Throne Jason | Chief Legal Officer | May 31, 2023 | Option Exercise | $7.01 | 432 | 3,028 | 432 | Jun 02, 2023, 05:29 PM |
Throne Jason | Chief Legal Officer | Jun 01, 2023 | Sale | $23.02 | 3,553 | 81,792 | 0 | Jun 02, 2023, 05:29 PM |
Throne Jason | Chief Legal Officer | May 31, 2023 | Sale | $23.00 | 432 | 9,938 | 0 | Jun 02, 2023, 05:29 PM |
Throne Jason | Chief Legal Officer | May 22, 2023 | Option Exercise | $7.01 | 500 | 3,505 | 500 | May 24, 2023, 05:51 PM |
Throne Jason | Chief Legal Officer | May 22, 2023 | Sale | $23.00 | 500 | 11,500 | 0 | May 24, 2023, 05:51 PM |
Stone Paul A. | Chief Financial Officer | Apr 13, 2023 | Option Exercise | $4.62 | 8,000 | 36,960 | 21,803 | Apr 14, 2023, 01:20 PM |
Hata Yujiro S | President and CEO | Apr 12, 2023 | Option Exercise | $4.31 | 11,601 | 50,000 | 677,887 | Apr 13, 2023, 04:11 PM |
Stone Paul A. | SVP, Chief Financial Officer | May 28, 2021 | Option Exercise | $11.36 | 859 | 9,762 | 13,803 | Apr 14, 2022, 04:10 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Oct 04, 2021 | Option Exercise | $11.08 | 1,500 | 16,620 | 80,289 | Oct 07, 2021, 04:11 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Oct 04, 2021 | Sale | $26.36 | 1,500 | 39,545 | 79,789 | Oct 07, 2021, 04:11 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Sep 08, 2021 | Option Exercise | $6.87 | 11,384 | 78,264 | 90,173 | Sep 09, 2021, 07:24 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Sep 07, 2021 | Option Exercise | $4.31 | 116 | 500 | 78,905 | Sep 09, 2021, 07:24 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Sep 08, 2021 | Sale | $27.42 | 11,384 | 312,093 | 78,989 | Sep 09, 2021, 07:24 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Sep 07, 2021 | Sale | $27.46 | 116 | 3,185 | 78,789 | Sep 09, 2021, 07:24 PM |
Stone Paul A. | SVP, Chief Financial Officer | Sep 07, 2021 | Sale | $27.42 | 2,500 | 68,542 | 12,944 | Sep 09, 2021, 05:41 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Sep 02, 2021 | Sale | $25.09 | 10,000 | 250,943 | 78,789 | Sep 07, 2021, 06:48 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Aug 09, 2021 | Option Exercise | $4.31 | 1,500 | 6,465 | 100,289 | Aug 11, 2021, 05:19 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Aug 09, 2021 | Sale | $22.98 | 11,500 | 264,269 | 89,189 | Aug 11, 2021, 05:19 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Jul 27, 2021 | Option Exercise | $5.62 | 10,000 | 56,150 | 108,789 | Jul 29, 2021, 05:18 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Jul 27, 2021 | Sale | $25.15 | 10,000 | 251,460 | 98,789 | Jul 29, 2021, 05:18 PM |
Throne Jason | SVP, General Counsel | Jul 27, 2021 | Option Exercise | $13.34 | 10,000 | 133,400 | 10,000 | Jul 29, 2021, 05:17 PM |
Throne Jason | SVP, General Counsel | Jul 27, 2021 | Sale | $25.17 | 10,000 | 251,683 | 0 | Jul 29, 2021, 05:17 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Jul 06, 2021 | Option Exercise | $6.92 | 1,500 | 10,380 | 100,289 | Jul 08, 2021, 07:01 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Jul 06, 2021 | Sale | $22.24 | 1,500 | 33,358 | 98,889 | Jul 08, 2021, 07:01 PM |
Throne Jason | SVP, General Counsel | Jul 06, 2021 | Option Exercise | $8.52 | 10,000 | 85,229 | 10,000 | Jul 08, 2021, 07:00 PM |
Throne Jason | SVP, General Counsel | Jul 06, 2021 | Sale | $22.24 | 10,000 | 222,408 | 3,532 | Jul 08, 2021, 07:00 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Feb 09, 2021 | Option Exercise | $6.92 | 5,000 | 34,600 | 103,789 | Feb 10, 2021, 07:31 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Feb 09, 2021 | Sale | $20.74 | 5,000 | 103,696 | 98,789 | Feb 10, 2021, 07:31 PM |
Lackner Mark | SVP, Head of Biology | Feb 10, 2021 | Option Exercise | $6.98 | 596 | 4,160 | 596 | Feb 10, 2021, 06:53 PM |
Lackner Mark | SVP, Head of Biology | Feb 09, 2021 | Option Exercise | $6.98 | 1,104 | 7,706 | 1,104 | Feb 10, 2021, 06:53 PM |
Lackner Mark | SVP, Head of Biology | Feb 08, 2021 | Option Exercise | $6.98 | 300 | 2,094 | 300 | Feb 10, 2021, 06:53 PM |
Lackner Mark | SVP, Head of Biology | Feb 10, 2021 | Sale | $21.00 | 596 | 12,516 | 0 | Feb 10, 2021, 06:53 PM |
Lackner Mark | SVP, Head of Biology | Feb 09, 2021 | Sale | $21.05 | 1,104 | 23,234 | 0 | Feb 10, 2021, 06:53 PM |
Lackner Mark | SVP, Head of Biology | Feb 08, 2021 | Sale | $21.01 | 300 | 6,302 | 200 | Feb 10, 2021, 06:53 PM |
BVF PARTNERS L P/IL | See Explanation of Responses | Feb 02, 2021 | Sale | $18.00 | 46,409 | 835,362 | 1,642,186 | Feb 04, 2021, 05:15 PM |
Lackner Mark | SVP, Head of Biology | Jan 26, 2021 | Option Exercise | $6.39 | 1,500 | 9,580 | 2,501 | Jan 28, 2021, 04:59 PM |
Lackner Mark | SVP, Head of Biology | Jan 26, 2021 | Sale | $18.46 | 2,501 | 46,158 | 800 | Jan 28, 2021, 04:59 PM |
Hata Yujiro S | President and CEO | Dec 22, 2020 | Option Exercise | $4.31 | 8,000 | 34,480 | 666,286 | Dec 23, 2020, 04:06 PM |
Dillon Michael P. | SVP, Chief Scientific Officer | Dec 18, 2020 | Option Exercise | $4.31 | 7,750 | 33,402 | 98,789 | Dec 22, 2020, 05:35 PM |
Throne Jason | SVP, General Counsel | Dec 04, 2020 | Sale | $15.37 | 1,979 | 30,410 | 1,579 | Dec 08, 2020, 04:03 PM |
5AM Ventures IV, L.P. | 10% Owner | Nov 11, 2020 | Sale | $13.66 | 800,000 | 10,928,000 | 2,187,428 | Nov 13, 2020, 08:53 PM |
BVF PARTNERS L P/IL | 10% Owner | Jun 30, 2020 | Buy | $13.32 | 2,531 | 33,704 | 1,667,420 | Jul 02, 2020, 06:51 PM |
BVF PARTNERS L P/IL | 10% Owner | Jun 22, 2020 | Buy | $13.93 | 19,732 | 274,960 | 1,665,899 | Jun 22, 2020, 07:52 PM |
BVF PARTNERS L P/IL | 10% Owner | Jun 19, 2020 | Buy | $14.39 | 98,264 | 1,413,970 | 1,655,375 | Jun 22, 2020, 07:52 PM |
Stone Paul A. | Chief Financial Officer | Jun 17, 2020 | Option Exercise | $4.62 | 3,100 | 14,322 | 18,100 | Jun 19, 2020, 07:46 PM |
Stone Paul A. | Chief Financial Officer | Jun 17, 2020 | Sale | $17.97 | 3,100 | 55,717 | 15,600 | Jun 19, 2020, 07:46 PM |
Lackner Mark | SVP, Head of Biology | Jun 17, 2020 | Option Exercise | $4.62 | 373 | 1,723 | 373 | Jun 18, 2020, 06:03 PM |
Lackner Mark | SVP, Head of Biology | Jun 16, 2020 | Option Exercise | $5.62 | 6,750 | 37,942 | 6,750 | Jun 18, 2020, 06:03 PM |
Lackner Mark | SVP, Head of Biology | Jun 16, 2020 | Sale | $14.93 | 6,750 | 100,761 | 0 | Jun 18, 2020, 06:03 PM |
Lackner Mark | SVP, Head of Biology | Jun 17, 2020 | Sale | $19.91 | 373 | 7,428 | 0 | Jun 18, 2020, 06:03 PM |
Throne Jason | VP, General Counsel | Jun 04, 2020 | Sale | $8.66 | 2,205 | 19,087 | 0 | Jun 08, 2020, 04:51 PM |
Lackner Mark | SVP, Head of Biology | Jun 02, 2020 | Sale | $9.21 | 845 | 7,779 | 437 | Jun 04, 2020, 05:40 PM |
Hata Yujiro S | President and CEO | Apr 15, 2020 | Option Exercise | $4.31 | 47,564 | 205,001 | 658,286 | Apr 16, 2020, 05:33 PM |
Stone Paul A. | Chief Financial Officer | Mar 30, 2020 | Option Exercise | $4.62 | 5,000 | 23,100 | 15,000 | Apr 01, 2020, 04:06 PM |
Hata Yujiro S | President and CEO | Jul 30, 2019 | Option Exercise | $4.31 | 15,000 | 64,650 | 610,722 | Aug 01, 2019, 12:20 PM |
Hager Jeffrey | SVP, Chief Technology Officer | Jul 26, 2019 | Option Exercise | $4.31 | 5,197 | 22,399 | 127,853 | Jul 30, 2019, 07:20 PM |
Stone Paul A. | SVP, General Counsel | Jul 26, 2019 | Option Exercise | $4.62 | 10,000 | 46,200 | 10,000 | Jul 29, 2019, 04:27 PM |
Hager Jeffrey | SVP, Chief Technology Officer | Jul 10, 2019 | Option Exercise | $4.31 | 7,145 | 30,795 | 122,656 | Jul 26, 2019, 12:50 PM |
Hager Jeffrey | SVP, Chief Technology Officer | Jun 19, 2019 | Option Exercise | $4.31 | 8,628 | 37,187 | 115,511 | Jul 26, 2019, 12:50 PM |
Alexandria Venture Investments, LLC | 10% Owner | May 28, 2019 | Buy | $10.00 | 50,000 | 500,000 | 432,384 | May 30, 2019, 06:12 PM |
DIEKMAN JOHN D | Director | May 28, 2019 | Buy | $10.00 | 250,000 | 2,500,000 | 2,844,545 | May 28, 2019, 09:14 PM |
Stone Paul A. | SVP, General Counsel | May 28, 2019 | Buy | $10.00 | 250,000 | 2,500,000 | 2,844,545 | May 28, 2019, 09:08 PM |
5AM Ventures IV, L.P. | 10% Owner | May 28, 2019 | Buy | $10.00 | 750,000 | 7,500,000 | 2,844,545 | May 28, 2019, 08:40 PM |
SHANNON TIMOTHY M | Director | May 28, 2019 | Buy | $10.00 | 400,000 | 4,000,000 | 2,660,713 | May 28, 2019, 04:56 PM |
CANAAN X L.P. | 10% Owner | May 28, 2019 | Buy | $10.00 | 400,000 | 4,000,000 | 2,660,713 | May 28, 2019, 04:55 PM |
Owner | Relationship | Date | Value($) |
Ruiz Briseno Andres | See Remarks | 02/09/2024 | 92,045 |
Hata Yujiro S | President and CEO | 02/08/2024 | 326,763 |
Hata Yujiro S | President and CEO | 02/09/2024 | 101,531 |
Hata Yujiro S | President and CEO | 02/09/2024 | 1,072,715 |
Hata Yujiro S | President and CEO | 02/08/2024 | 3,422,835 |
Hata Yujiro S | President and CEO | 02/01/2024 | 2,707 |
Hata Yujiro S | President and CEO | 02/01/2024 | 28,260 |
Ruiz Briseno Andres | See Remarks | 01/22/2024 | 84,050 |
Ruiz Briseno Andres | See Remarks | 01/12/2024 | 76,026 |
Hata Yujiro S | President and CEO | 01/12/2024 | 52,845 |
Hata Yujiro S | President and CEO | 01/16/2024 | 270,405 |
Hata Yujiro S | President and CEO | 01/12/2024 | 490,913 |
Hata Yujiro S | President and CEO | 01/16/2024 | 2,519,968 |
Throne Jason | Chief Legal Officer | 12/18/2023 | 70,100 |
Throne Jason | Chief Legal Officer | 12/15/2023 | 133,400 |
Throne Jason | Chief Legal Officer | 12/15/2023 | 350,371 |
Hata Yujiro S | President and CEO | 12/15/2023 | 323,250 |
Hata Yujiro S | President and CEO | 12/15/2023 | 2,627,618 |
Ruiz Briseno Andres | See Remarks | 12/14/2023 | 68,002 |
Throne Jason | Chief Legal Officer | 11/03/2023 | 66,396 |
Throne Jason | Chief Legal Officer | 11/03/2023 | 155,360 |
Throne Jason | Chief Legal Officer | 09/12/2023 | 12,860 |
Throne Jason | Chief Legal Officer | 09/12/2023 | 30,005 |
Throne Jason | Chief Legal Officer | 09/05/2023 | 22,338 |
Throne Jason | Chief Legal Officer | 09/01/2023 | 27,006 |
Throne Jason | Chief Legal Officer | 09/05/2023 | 52,160 |
Throne Jason | Chief Legal Officer | 09/01/2023 | 63,063 |
Ruiz Briseno Andres | See Remarks | 09/01/2023 | 60,016 |
Stone Paul A. | Chief Financial Officer | 08/29/2023 | 144,352 |
Stone Paul A. | Chief Financial Officer | 08/21/2023 | 25,819 |
Stone Paul A. | Chief Financial Officer | 08/18/2023 | 100,820 |
Stone Paul A. | Chief Financial Officer | 08/16/2023 | 5,285 |
Throne Jason | Chief Legal Officer | 08/09/2023 | 66,700 |
Throne Jason | Chief Legal Officer | 08/09/2023 | 125,429 |
Stone Paul A. | Chief Financial Officer | 08/09/2023 | 62,613 |
Throne Jason | Chief Legal Officer | 07/10/2023 | 95,740 |
Throne Jason | Chief Legal Officer | 07/10/2023 | 218,178 |
Throne Jason | Chief Legal Officer | 06/01/2023 | 24,907 |
Throne Jason | Chief Legal Officer | 05/31/2023 | 3,028 |
Throne Jason | Chief Legal Officer | 06/01/2023 | 81,792 |
Throne Jason | Chief Legal Officer | 05/31/2023 | 9,938 |
Throne Jason | Chief Legal Officer | 05/22/2023 | 3,505 |
Throne Jason | Chief Legal Officer | 05/22/2023 | 11,500 |
Stone Paul A. | Chief Financial Officer | 04/13/2023 | 36,960 |
Hata Yujiro S | President and CEO | 04/12/2023 | 50,000 |
Stone Paul A. | SVP, Chief Financial Officer | 05/28/2021 | 9,762 |
Dillon Michael P. | SVP, Chief Scientific Officer | 10/04/2021 | 16,620 |
Dillon Michael P. | SVP, Chief Scientific Officer | 10/04/2021 | 39,545 |
Dillon Michael P. | SVP, Chief Scientific Officer | 09/08/2021 | 78,264 |
Dillon Michael P. | SVP, Chief Scientific Officer | 09/07/2021 | 500 |
Dillon Michael P. | SVP, Chief Scientific Officer | 09/08/2021 | 312,093 |
Dillon Michael P. | SVP, Chief Scientific Officer | 09/07/2021 | 3,185 |
Stone Paul A. | SVP, Chief Financial Officer | 09/07/2021 | 68,542 |
Dillon Michael P. | SVP, Chief Scientific Officer | 09/02/2021 | 250,943 |
Dillon Michael P. | SVP, Chief Scientific Officer | 08/09/2021 | 6,465 |
Dillon Michael P. | SVP, Chief Scientific Officer | 08/09/2021 | 264,269 |
Dillon Michael P. | SVP, Chief Scientific Officer | 07/27/2021 | 56,150 |
Dillon Michael P. | SVP, Chief Scientific Officer | 07/27/2021 | 251,460 |
Throne Jason | SVP, General Counsel | 07/27/2021 | 133,400 |
Throne Jason | SVP, General Counsel | 07/27/2021 | 251,683 |
Dillon Michael P. | SVP, Chief Scientific Officer | 07/06/2021 | 10,380 |
Dillon Michael P. | SVP, Chief Scientific Officer | 07/06/2021 | 33,358 |
Throne Jason | SVP, General Counsel | 07/06/2021 | 85,229 |
Throne Jason | SVP, General Counsel | 07/06/2021 | 222,408 |
Dillon Michael P. | SVP, Chief Scientific Officer | 02/09/2021 | 34,600 |
Dillon Michael P. | SVP, Chief Scientific Officer | 02/09/2021 | 103,696 |
Lackner Mark | SVP, Head of Biology | 02/10/2021 | 4,160 |
Lackner Mark | SVP, Head of Biology | 02/09/2021 | 7,706 |
Lackner Mark | SVP, Head of Biology | 02/08/2021 | 2,094 |
Lackner Mark | SVP, Head of Biology | 02/10/2021 | 12,516 |
Lackner Mark | SVP, Head of Biology | 02/09/2021 | 23,234 |
Lackner Mark | SVP, Head of Biology | 02/08/2021 | 6,302 |
BVF PARTNERS L P/IL | See Explanation of Responses | 02/02/2021 | 835,362 |
Lackner Mark | SVP, Head of Biology | 01/26/2021 | 9,580 |
Lackner Mark | SVP, Head of Biology | 01/26/2021 | 46,158 |
Hata Yujiro S | President and CEO | 12/22/2020 | 34,480 |
Dillon Michael P. | SVP, Chief Scientific Officer | 12/18/2020 | 33,402 |
Throne Jason | SVP, General Counsel | 12/04/2020 | 30,410 |
5AM Ventures IV, L.P. | 10% Owner | 11/11/2020 | 10,928,000 |
BVF PARTNERS L P/IL | 10% Owner | 06/30/2020 | 33,704 |
BVF PARTNERS L P/IL | 10% Owner | 06/22/2020 | 274,960 |
BVF PARTNERS L P/IL | 10% Owner | 06/19/2020 | 1,413,970 |
Stone Paul A. | Chief Financial Officer | 06/17/2020 | 14,322 |
Stone Paul A. | Chief Financial Officer | 06/17/2020 | 55,717 |
Lackner Mark | SVP, Head of Biology | 06/17/2020 | 1,723 |
Lackner Mark | SVP, Head of Biology | 06/16/2020 | 37,942 |
Lackner Mark | SVP, Head of Biology | 06/16/2020 | 100,761 |
Lackner Mark | SVP, Head of Biology | 06/17/2020 | 7,428 |
Throne Jason | VP, General Counsel | 06/04/2020 | 19,087 |
Lackner Mark | SVP, Head of Biology | 06/02/2020 | 7,779 |
Hata Yujiro S | President and CEO | 04/15/2020 | 205,001 |
Stone Paul A. | Chief Financial Officer | 03/30/2020 | 23,100 |
Hata Yujiro S | President and CEO | 07/30/2019 | 64,650 |
Hager Jeffrey | SVP, Chief Technology Officer | 07/26/2019 | 22,399 |
Stone Paul A. | SVP, General Counsel | 07/26/2019 | 46,200 |
Hager Jeffrey | SVP, Chief Technology Officer | 07/10/2019 | 30,795 |
Hager Jeffrey | SVP, Chief Technology Officer | 06/19/2019 | 37,187 |
Alexandria Venture Investments, LLC | 10% Owner | 05/28/2019 | 500,000 |
DIEKMAN JOHN D | Director | 05/28/2019 | 2,500,000 |
Stone Paul A. | SVP, General Counsel | 05/28/2019 | 2,500,000 |
5AM Ventures IV, L.P. | 10% Owner | 05/28/2019 | 7,500,000 |
SHANNON TIMOTHY M | Director | 05/28/2019 | 4,000,000 |
CANAAN X L.P. | 10% Owner | 05/28/2019 | 4,000,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 5,436,668 | 0.00493% | 18.35% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,925,094 | 0.22% | 27.9% | Other |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,630,292 | 1.73% | 15.94% | Other |
CAPITAL RESEARCH GLOBAL INVESTORS | 1,976,870 | 0.02% | 43.58% | Growth At A Reasonable Price |
HOLOCENE ADVISORS, LP | 1,700,135 | 0.24% | 64.59% | Growth At A Reasonable Price |
GEODE CAPITAL MANAGEMENT, LLC | 1,351,337 | 0.00503% | 16.38% | Other |
BAKER BROS. ADVISORS LP | 1,062,123 | 0.43% | No change | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 912,786 | 0.39% | 30.87% | Growth |
PLATINUM INVESTMENT MANAGEMENT LTD | 662,343 | 0.96% | -13.61% | Growth At A Reasonable Price, Value |
FISHER ASSET MANAGEMENT, LLC | 539,676 | 0.01% | 1611.9% | Other |
D. E. SHAW & CO., INC. | 529,506 | 0.02% | 21.35% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 466,271 | 0.03% | New | Event Driven |
CANDRIAM S.C.A. | 395,019 | 0.1% | -8.14% | Other |
UBS OCONNOR LLC | 74,575 | 0.19% | -40.88% | Value |
ALPS ADVISORS INC | 42,450 | 0.01% | -0.07% | Other |
TUDOR INVESTMENT CORP ET AL | 20,931 | 0.00566% | Exited | Event Driven, Other |
AQR CAPITAL MANAGEMENT LLC | 15,879 | 0.00106% | -7.05% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View